Sunny Pharmtech Inc. (TPEX:6676)
20.65
-0.05 (-0.24%)
Feb 21, 2025, 1:43 PM CST
Sunny Pharmtech Revenue
Sunny Pharmtech had revenue of 233.56M TWD in the half year ending June 30, 2024, with 50.30% growth. This brings the company's revenue in the last twelve months to 485.01M, up 27.11% year-over-year. In the year 2023, Sunny Pharmtech had annual revenue of 428.83M with 19.26% growth.
Revenue (ttm)
485.01M
Revenue Growth
+27.11%
P/S Ratio
6.29
Revenue / Employee
3.37M
Employees
138
Market Cap
3.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 428.83M | 69.24M | 19.26% |
Dec 31, 2022 | 359.59M | 118.59M | 49.21% |
Dec 31, 2021 | 241.00M | -178.94M | -42.61% |
Dec 31, 2020 | 419.94M | 185.46M | 79.09% |
Dec 31, 2019 | 234.48M | 91.69M | 64.21% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Lumosa Therapeutics | 37.82M |
Oneness Biotech | 112.20M |
Polaris Group | 75.65M |
Pegavision | 7.06B |